Hexacare Pharmaceuticals

Chennai, India Founded: 2015 • Age: 11 yrs
Trader and wholesaler of anti-cancer drugs, injections, tablets, and pharmaceutical products.
Annual revenue $3.5M Latest available
Total funding - Funding intelligence
Employees 21 Tracked headcount
Investors - Known backers
Products 8 Services tracked
Competitors 7 Brand Intelligence

About Hexacare Pharmaceuticals

Hexacare Pharmaceuticals is a company based in Chennai (India) founded in 2015. It operates as a B2B. The company has 21 employees as of March 31, 2023. Hexacare Pharmaceuticals offers products and services including Hertraz Trastuzumab 150 Mg Injection, Biomus 0.5 mg, Reditux Rituximab 500 Mg Injection, Tenohep 300 Mg 10 Tablets, and Trioday 30 Tablets. Hexacare Pharmaceuticals operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

  • Headquarter Chennai, India
  • Employees 21 as on 31 Mar, 2023
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Hexacare Pharmaceuticals Private Limited
  • Date of Incorporation 14 Jul, 2015
  • Jurisdiction Chennai, Tamil Nadu, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $3.54 M (USD)
    -2.1
    as on Mar 31, 2023
  • Net Profit
    $25.95 K (USD)
    29.69
    as on Mar 31, 2023
  • EBITDA
    $96.48 K (USD)
    -43.69
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    21

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Hexacare Pharmaceuticals

Hexacare Pharmaceuticals offers a comprehensive portfolio of products and services, including Hertraz Trastuzumab 150 Mg Injection, Biomus 0.5 mg, Reditux Rituximab 500 Mg Injection, Tenohep 300 Mg 10 Tablets, and Trioday 30 Tablets.

Product name locked
Category locked
Primary

Injection used for treating cancer patients.

Product name locked
Category locked
Locked

Medication for cancer therapy and management.

Product name locked
Category locked
Locked

Injection for targeted cancer treatment.

Product name locked
Category locked
Locked

Tablets for antiviral and cancer-related applications.

Product name locked
Category locked
Locked

Tablets used in virology and oncology treatments.

Product name locked
Category locked
Locked

Injection for nephrology and related conditions.

Product name locked
Category locked
Locked

Tablets for cancer chemotherapy.

Product name locked
Category locked
Locked

Injection for oncology purposes.

Funding Insights of Hexacare Pharmaceuticals

Premium access

Detailed funding history for Hexacare Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Hexacare Pharmaceuticals

Investments
Premium access

Investment portfolio details for Hexacare Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Hexacare Pharmaceuticals

Premium access

Detailed financials for Hexacare Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Hexacare Pharmaceuticals Comparisons

Hexacare Pharmaceuticals Primary company
Description
Trader and wholesaler of anti-cancer drugs, injections, tabl...
Location
Chennai, India
Founded Year
2015
Annual Revenue
$3.54 M (USD)
Net Profit
$25.95 K (USD)
EBITDA
$96.48 K (USD)
Employees
21
As of 2023
Premium access

Peer comparison for Hexacare Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Hexacare Pharmaceuticals

Hexacare Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical distribution and supply chain services are provided globally.
Locked Locked Locked
India's leading healthcare products distribution platform
Locked Locked Locked
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
Locked Locked Locked
Provider of medical equipment, devices, and drugs distribution services
Locked Locked Locked
Serves as a distributor of a wide range of pharmaceutical drugs.
Locked Locked Locked
Distributor of pharmaceutical raw materials
Premium access

Detailed competitors of Hexacare Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Hexacare Pharmaceuticals

Premium access

Complete news archive for Hexacare Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hexacare Pharmaceuticals

Hexacare Pharmaceuticals was founded in 2015.

Hexacare Pharmaceuticals is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

As of Mar 31, 2023, the latest employee count at Hexacare Pharmaceuticals is 21.

Annual revenue of Hexacare Pharmaceuticals is $3.54M as on Mar 31, 2023.

Hexacare Pharmaceuticals Private Limited operates as a trader and wholesaler in Chennai, Tamil Nadu, India, specializing in anti-cancer medicines, drugs, injections, tablets, and products for oncology, nephrology, and virology. They distribute branded and generic life-saving medicines through wholesale channels, serving healthcare providers and distributors with a focus on quality and timely supply. The company emphasizes specialized pharmaceutical trading to meet medical needs.

Hexacare Pharmaceuticals's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.

Hexacare Pharmaceuticals offers Hertraz Trastuzumab 150 Mg Injection, Biomus 0.5 mg, Reditux Rituximab 500 Mg Injection, Tenohep 300 Mg 10 Tablets, and 4 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available